DC661

CAS : 1872387-43-3

Ref. 3D-XZC38743

Informations sur le produit

• Nom: DC661
• CAS: 1872387-43-3

Description

DC-661 is a new compound that is being developed for the treatment of cancer. DC-661 is a stable complex of an amp-activated protein with rapamycin and has shown to have anti-cancer effects in cell culture. The mechanism of action of DC-661 against cancer cells may be due to its ability to induce autophagy, a process that eliminates dysfunctional or unnecessary cellular components. This compound also inhibits the expression of death proteins, which leads to apoptosis (cell death). Pentobarbital sodium, an anaesthetic agent, has been shown to inhibit autophagy in mice and this may be one possible mechanism for its use as an anticancer agent.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 552.58 g/mol
• Formule: C₃₁H₃₉Cl₂N₅
• Degré de pureté: Min. 95%